SEC Filings - Ultragenyx Pharmaceutical Inc.

SEC Filings

Filing date	Description	Form	View
Jun 28, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-21-043535.pdf 0001209191-21-043535.xls
Jun 28, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-21-043538.pdf 0001209191-21-043538.xls
Jun 28, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-21-043540.pdf 0001209191-21-043540.xls
Jun 28, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-21-043543.pdf 0001209191-21-043543.xls
Jun 28, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-21-043545.pdf 0001209191-21-043545.xls
Jun 28, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-21-043547.pdf 0001209191-21-043547.xls
Jun 28, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-21-043549.pdf 0001209191-21-043549.xls
Jun 25, 2021	Report of unscheduled material events or corporate event	8-K	View HTML 0000950170-21-000388.pdf 0000950170-21-000388.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jun 23, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-21-042812.pdf 0001209191-21-042812.xls
Jun 11, 2021	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-21-040108.pdf 0001209191-21-040108.xls

INVESTORS & MEDIA

SHAREHOLDER TOOLS